Study: NCT05580003

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07817883
Description: Oral suspension or solid oral formulation(s)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo suspension

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo suspension

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo suspension

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: midazolam oral solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: midazolam oral solution

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: Moxifloxacin 400 mg tablet